GGrantIndex
← Leaderboards

Tianyan Gao

University Of California San Diego

$8,810,083
Attributed
$10,269,951
Total exposure
5
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.3M · FY200525
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,930,984 · 6

By mechanism

R01$9,620,097 · 4
P01$1,661,033 · 1
K01$649,854 · 1

Top collaborators

Others in their field

Top investigators on “In Vivo

Research focus

In VivoMediatingCancer CellColorectal CancerColon CarcinomaCellsMolecularCell ProliferationPathway InteractionsAutomobile DrivingMalignant NeoplasmsCessation Of LifeSignal TransductionRegulationTumorigenesisCancer EtiologyInsightProtein PhosphataseOncogenicPlayPhosphorylationIntestinesKnockout MiceUnited States

Grant awards (39)

Fatty Acid Synthase as a Novel Molecular Target for Colon Cancer Treatment$402,968
R01 · FY2025 · CA · contact PI
Study of PTPRF-Mediated Regulation of Wnt Signaling$347,125
R01 · FY2025 · GM · contact PI
Fatty Acid Synthase as a Novel Molecular Target for Colon Cancer Treatment$402,968
R01 · FY2024 · CA · contact PI
Study of PTPRF-Mediated Regulation of Wnt Signaling$347,125
R01 · FY2024 · GM · contact PI
The Role of PHLPP in Colon Cancer$343,537
R01 · FY2024 · CA · contact PI
The Role of PHLPP in Colon Cancer$64,575
R01 · FY2024 · CA · contact PI
Diversity Supplement for Haley Stanczyk$54,489
R01 · FY2024 · GM · contact PI
Study of PTPRF-Mediated Regulation of Wnt Signaling- Supplement$37,644
R01 · FY2024 · GM · contact PI
The Role of PHLPP in Colon Cancer$361,701
R01 · FY2023 · CA · contact PI
Study of PTPRF-Mediated Regulation of Wnt Signaling$347,125
R01 · FY2023 · GM · contact PI
Diversity Supplement Carolina Galeano-Naranjo$67,241
R01 · FY2023 · CA · contact PI
The Role of PHLPP in Colon Cancer$389,590
R01 · FY2022 · CA · contact PI
Altered Lipid Metabolism as a Novel Target for Colon Cancer Treatment$425,312
R01 · FY2021 · CA
The Role of PHLPP in Colon Cancer$326,096
R01 · FY2021 · CA · contact PI
Lafora Epilepsy – Basic mechanisms to therapy$153,675
P01 · FY2021 · NS · contact PI
Lafora Epilepsy - Basic mechanisms to therapy$1,507,358
P01 · FY2020 · NS · contact PI
Altered Lipid Metabolism as a Novel Target for Colon Cancer Treatment$425,312
R01 · FY2020 · CA
The Role of PHLPP in Colon Cancer$361,929
R01 · FY2020 · CA · contact PI
Altered Lipid Metabolism as a Novel Target for Colon Cancer Treatment$412,552
R01 · FY2019 · CA
The Role of PHLPP in Colon Cancer$346,714
R01 · FY2019 · CA · contact PI
Altered Lipid Metabolism as a Novel Target for Colon Cancer Treatment$425,312
R01 · FY2018 · CA
The Role of PHLPP in Colon Cancer$357,438
R01 · FY2018 · CA · contact PI
The Role of PHLPP in Colon Cancer$138,690
R01 · FY2018 · CA · contact PI
Altered Lipid Metabolism as a Novel Target for Colon Cancer Treatment$425,312
R01 · FY2017 · CA
The Role of PHLPP in Colon Cancer$357,438
R01 · FY2017 · CA · contact PI
The Role of PHLPP in Colon Cancer$357,438
R01 · FY2016 · CA · contact PI
The Role of PHLPP in Colon Cancer$356,745
R01 · FY2015 · CA · contact PI
The Role of PHLPP in Colon Cancer$253,301
R01 · FY2014 · CA · contact PI
The Role of PHLPP in Colon Cancer$245,467
R01 · FY2013 · CA · contact PI
The Role of PHLPP in Colon Cancer$75,510
R01 · FY2012 · CA · contact PI
The Role of PHLPP in Colon Cancer$298,893
R01 · FY2011 · CA · contact PI
The Role of PHLPP in Colon Cancer$308,138
R01 · FY2010 · CA · contact PI
The Role of PHLPP in Colon Cancer$313,325
R01 · FY2009 · CA · contact PI
The Role of PHLPP in Colon Cancer$243,087
R01 · FY2009 · CA · contact PI
Phosphatase mediated regulation of PKC and Akt$148,434
K01 · FY2007 · CA · contact PI
Phosphatase mediated regulation of PKC and Akt$145,683
K01 · FY2006 · CA · contact PI
Phosphatase mediated regulation of PKC and Akt$121,413
K01 · FY2005 · CA
Phosphatase mediated regulation of PKC and Akt$118,821
K01 · FY2004 · CA
Phosphatase mediated regulation of PKC and Akt$115,503
K01 · FY2003 · CA